XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.25.2

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
Segment Information | Segment Information The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the quarter ended September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment, with no impact on the Company’s consolidated results of operations or financial position. The Company recast its historical geographic segment information to conform to the new reporting structure in 2024. The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The Chairman of the Board, President and Chief Executive Officer has been determined to be the Company’s Chief Operating Decision Maker and he uses Operating Profit to assess performance and to allocate resources for each of the reportable operating segments in the budgeting and forecasting process. Asset information by segment is not utilized for purposes of assessing performance or allocating resources, and therefore such information has not been presented. The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments. Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Corporate Operating profit (loss) for the three months ended June 30, 2025 included acquisition-related costs of $9. Corporate Operating profit (loss) for the three months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $27. Corporate Operating profit (loss) for the six months ended June 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9. Corporate Operating profit (loss) for the six months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $63. The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:
| Three Months Ended June 30, 2025
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 1,027 |  |  | $ | 403 |  |  | $ | 417 |  |  | $ | 13 |  |  | $ | 194 |
Latin America | 1,207 |  |  | 527 |  |  | 318 |  |  | (6) |  |  | 367 |
Europe | 738 |  |  | 275 |  |  | 272 |  |  | 7 |  |  | 184 |
Asia Pacific | 687 |  |  | 265 |  |  | 242 |  |  | (7) |  |  | 187 |
Africa/Eurasia | 295 |  |  | 117 |  |  | 110 |  |  | 3 |  |  | 65 |
Total Oral, Personal and Home Care | 3,954 |  |  |  |  |  |  |  |  | 997 |
Pet Nutrition | 1,157 |  |  | 462 |  |  | 430 |  |  | — |  |  | 264 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (181) |
Total | $ | 5,110 |  |  |  |  |  |  |  |  | $ | 1,080 |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
| Six Months Ended June 30, 2025
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 2,025 |  |  | $ | 780 |  |  | $ | 832 |  |  | $ | 23 |  |  | $ | 390 |
Latin America | 2,350 |  |  | 1,014 |  |  | 633 |  |  | (13) |  |  | 715 |
Europe | 1,427 |  |  | 532 |  |  | 526 |  |  | 14 |  |  | 356 |
Asia Pacific | 1,378 |  |  | 526 |  |  | 481 |  |  | (15) |  |  | 385 |
Africa/Eurasia | 566 |  |  | 221 |  |  | 216 |  |  | 7 |  |  | 122 |
Total Oral, Personal and Home Care | 7,746 |  |  |  |  |  |  |  |  | 1,968 |
Pet Nutrition | 2,275 |  |  | 899 |  |  | 852 |  |  | 1 |  |  | 523 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (334) |
Total | $ | 10,021 |  |  |  |  |  |  |  |  | $ | 2,156 |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
| Three Months Ended June 30, 2024
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 1,037 |  |  | $ | 396 |  |  | $ | 426 |  |  | $ | 3 |  |  | $ | 213 |
Latin America | 1,267 |  |  | 504 |  |  | 353 |  |  | (6) |  |  | 417 |
Europe | 685 |  |  | 258 |  |  | 251 |  |  | 7 |  |  | 169 |
Asia Pacific | 682 |  |  | 260 |  |  | 232 |  |  | (6) |  |  | 195 |
Africa/Eurasia | 273 |  |  | 105 |  |  | 103 |  |  | 1 |  |  | 64 |
Total Oral, Personal and Home Care | 3,944 |  |  |  |  |  |  |  |  | 1,058 |
Pet Nutrition | 1,114 |  |  | 459 |  |  | 420 |  |  | 1 |  |  | 235 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (201) |
Total | $ | 5,058 |  |  |  |  |  |  |  |  | $ | 1,092 |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income.
| Six Months Ended June 30, 2024
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 2,073 |  |  | $ | 786 |  |  | $ | 845 |  |  | $ | 15 |  |  | $ | 427 |
Latin America | 2,520 |  |  | 1,005 |  |  | 698 |  |  | (5) |  |  | 822 |
Europe | 1,358 |  |  | 525 |  |  | 497 |  |  | 15 |  |  | 321 |
Asia Pacific | 1,408 |  |  | 544 |  |  | 474 |  |  | (13) |  |  | 402 |
Africa/Eurasia | 549 |  |  | 211 |  |  | 202 |  |  | 6 |  |  | 130 |
Total Oral, Personal and Home Care | 7,908 |  |  |  |  |  |  |  |  | 2,102 |
Pet Nutrition | 2,216 |  |  | 941 |  |  | 833 |  |  | 10 |  |  | 433 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (397) |
Total | $ | 10,124 |  |  |  |  |  |  |  |  | $ | 2,139 |
Note: Table may not sum due to rounding. (1) Other (income) expense, net primarily includes amortization of intangible assets and equity income. The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
| Three Months Ended |  | Six Months Ended
| June 30, |  | June 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net sales |  |  |  |  |  |  |
Oral Care | 43 | % |  | 42 | % |  | 44 | % |  | 43 | %
Personal Care | 18 | % |  | 19 | % |  | 17 | % |  | 18 | %
Home Care | 16 | % |  | 17 | % |  | 16 | % |  | 17 | %
Pet Nutrition | 23 | % |  | 22 | % |  | 23 | % |  | 22 | %
Total Net sales | 100 | % |  | 100 | % |  | 100 | % |  | 100 | %
Capital expenditures and depreciation and amortization expense by segment were:
| Three Months Ended |  | Six Months Ended |  |
| June 30, |  | June 30, |  |
| 2025 |  | 2024 |  | 2025 |  | 2024 |  |  |  |
Capital expenditures |  |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |  |
North America | $ | 14 |  |  | $ | 13 |  |  | $ | 30 |  |  | $ | 21 |  |  |  |  |
Latin America | 21 |  |  | 25 |  |  | 50 |  |  | 46 |  |  |  |  |
Europe | 12 |  |  | 13 |  |  | 20 |  |  | 20 |  |  |  |  |
Asia Pacific | 19 |  |  | 10 |  |  | 32 |  |  | 19 |  |  |  |  |
Africa/Eurasia | 2 |  |  | 1 |  |  | 4 |  |  | 3 |  |  |  |  |
Total Oral, Personal and Home Care | 68 |  |  | 62 |  |  | 136 |  |  | 109 |  |  |  |  |
Pet Nutrition | 22 |  |  | 31 |  |  | 43 |  |  | 84 |  |  |  |  |
Corporate | 18 |  |  | 24 |  |  | 53 |  |  | 50 |  |  |  |  |
Total Capital expenditures | $ | 108 |  |  | $ | 117 |  |  | $ | 232 |  |  | $ | 243 |  |  |  |  |
| Three Months Ended |  | Six Months Ended |  |
| June 30, |  | June 30, |  |
| 2025 |  | 2024 |  | 2025 |  | 2024 |  |  |  |
Depreciation and amortization |  |  |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |  |  |
North America | $ | 30 |  |  | $ | 32 |  |  | $ | 60 |  |  | $ | 63 |  |  |  |  |
Latin America | 27 |  |  | 26 |  |  | 51 |  |  | 53 |  |  |  |  |
Europe | 16 |  |  | 16 |  |  | 32 |  |  | 32 |  |  |  |  |
Asia Pacific | 20 |  |  | 20 |  |  | 40 |  |  | 40 |  |  |  |  |
Africa/Eurasia | 2 |  |  | 2 |  |  | 4 |  |  | 4 |  |  |  |  |
Total Oral, Personal and Home Care | 95 |  |  | 96 |  |  | 187 |  |  | 192 |  |  |  |  |
Pet Nutrition | 31 |  |  | 37 |  |  | 63 |  |  | 67 |  |  |  |  |
Corporate | 25 |  |  | 24 |  |  | 49 |  |  | 48 |  |  |  |  |
Total Depreciation and amortization | $ | 151 |  |  | $ | 157 |  |  | $ | 299 |  |  | $ | 307 |  |  |  |  |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration